Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test: Comparison of Biozek COVID-19 Antigen Rapid Test Results Performed on Self-collected Samples by the Subjects, to Results of COVID-19 RT-PCR as a Standard of Care

NCT04926779 is registered in ClinicalTrials.gov with Mach-E B.V. as lead sponsor.

NCT NCT04926779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04926779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test: Comparison of Biozek COVID-19 Antigen Rapid Test Results Performed on Self-collected Samples by the Subjects, to Results of COVID-19 RT-PCR as a Standard of Care
Lead sponsor
Mach-E B.V.
Phase
Not applicable
Overall status
Completed
Start date
May 24, 2021
Completion date
November 4, 2022
Enrollment
185 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 testing